Giancarlo D'Ambrosio

Latham & Watkins has advised FC Internazionale Milano on the extension of the club’s longstanding partnership with Nike, one of the longest in European Football. The new agreement will remain consistent with the core values, highlighting the mutual spirit of innovation as well as placing focus on equity and support for the women’s game. The Latham team was led by London partner Patrick Mitchell and Milan partner Giancarlo D’Ambrosio, with associates Stewart Robinson and Marco Martino.~~

Jul 13

1 min

Kirkland & Ellis counseled Allied Industrial Partners LLC (AIP), an industrial-focused private equity firm, on its strategic investment in Wall Recycling, LLC, a leading regional provider of solid waste hauling, disposal and recycling services for municipal, commercial and industrial waste generators throughout North Carolina. Wall Recycling will continue to be led by its founder and CEO Dan Wall. The terms of the transaction were not disclosed. Read Allied Industrial Partners’ press release The Kirkland team was led by corporate partner Thomas Laughlin and associates Adam Wojcik and Andrei Bucur; debt finance partners Will Bos and Jordan Roberts and associates Daniel Kirksey, Christina Godard and Annie Crea; investment funds partners Matt Nadworny and Linda Dahl and associates Tomi Olutoye, Keisha Wiley and Nick D’Ambrosio; and tax partners Steve Butler and Jon Nelsen and associates Ryan Phelps and Courtney Loyack.

Oct 7

1 min

Kirkland & Ellis advised Patient Square Capital (Patient Square), a leading health care investment firm, on the formation of its inaugural fund, Patient Square Equity Partners (PSEP), with approximately $3.9 billion in total committed capital as of its final closing. PSEP surpassed its $3 billion target and is both the largest first-time private equity fund ever raised and the largest fund ever raised by a dedicated health-care-focused private equity, growth equity or venture capital firm. At the final close, Patient Square’s total assets under management (AUM) stood at approximately $5.9 billion, including significant co-investment commitments from leading institutional investors. Patient Square invests broadly across the health care industry, including development-stage therapeutics; commercial-stage pharmaceuticals; medical devices, diagnostics and life science tools; health care providers; and technology-enabled and other services. Commitments to PSEP were secured from a diverse and global set of institutional investors, including leading sovereign wealth funds, pension funds, endowments, foundations, family offices, hospital systems, consultants, private wealth platforms and insurance companies. The final closing of PSEP was announced on February 1, 2023. Read Patient Square’s press release The Kirkland team was led by investment funds partners Daniel Lavon-Krein, Paul Watt and Barry Le Vine, and included investment funds partners Mark Boyagi and Amanda Strickler, with assistance from associates Jackie Ting, Nathan Calko, Alex Burt, Wilford Ng, Bojun Xu, Cynthia Situ, Alicia Nakhjavan and Devon Salge; investment funds regulatory partners Alpa Patel, Lisa Cawley and Zach Milloy and associates Nick D’Ambrosio, Radhika Kshatriya and Jade Bernard; tax partners Lee Morlock, Joel Peters-Fransen and associate Allison Bray; debt finance partner Aditi Iyer and associates Adnan Hussain and Alex Straka; investment funds ERISA partner Sabrina Glaser; and ESG & impact partner Alex Farmer and associates Emilie Jones and Donna Ni. The Patient Square team also includes restructuring partner Edward Sassower; corporate partners Michael Weisser, Ryan Brissette and Maggie Flores; debt finance partner Jason Kanner; and tax partner Mark Schwed.

Feb 1

1 min

Kirkland & Ellis advised Quinbrook Infrastructure Partners, a specialist global investment manager focused exclusively on the infrastructure needed for the energy transition, on the final closing of the Net Zero Power Fund (NZPF). Quinbrook secured a total of $3 billion of new capital commitments in aggregate across the fund and co-investment vehicles for the NZPF strategy. NZPF is Quinbrook’s fifth successive energy transition focused fund raised to date and attracted new institutional investors from the United States, Canada, Australia, UK, Sweden, Norway, Finland and the EU, comprised of a mix of pension, sovereign and insurance institutions along with a number of fund of funds, endowments and family offices. Quinbrook has already invested and committed more than half of total committed capital to date and expects to be fully committed within the next 12 months. Read the transaction press release The Kirkland team was led by investment funds partners Matthew Nadworny and Laura Stake and associates Katherine Chernova and Jordan Redler; tax partner Steve Butler; and ESG & Impact partner Dan D'Ambrosio.

Aug 6

1 min

Freshfields conseille DB Finanziaria S.p.A., Kartesia et Farallon Capital Management sur la signature d’un accord de cession à NextChem (MAIRE) de la totalité du capital social du Groupe Ballestra (« Ballestra »), leader mondial en matière de licences, de conception et d’ingénierie d’usines de traitement, ainsi que de technologies et d’équipements exclusifs pour l’industrie chimique. Fondé en 1960 et basé à Milan, le groupe Ballestra dirige un ensemble de sociétés comprenant BUSS ChemTech AG (Suisse) et Ballestra Engineering and Projects Pvt. Ltd (Inde). Le groupe Ballestra est présent dans plus de 120 pays, avec environ 450 employés et des bureaux en Europe et en Asie, au service d’une clientèle bien établie et forte d’une expérience considérable, avec plus de 6 400 usines installées dans le monde entier. L’équipe Freshfields était coordonnée par Yann Gozal (Paris) et Giancarlo D'Ambrosio (Milan), associés, ainsi que Kamile Bougdira (Paris) et Barbara Degli Esposti (Milan), collaborateurs seniors, et Romain Giraud (Paris) et Elena Martegiani (Milan), collaborateurs. Charlotte Colin-Dubuisson (Paris), associée, Sara Gil Garcia (Paris), counsel, et Paul Lesourd (Paris), collaborateur, sont intervenus sur les aspects de droit de la concurrence.

Jan 15

1 min